ADME-Enabling Technologies in Drug Design and Development by Donglu Zhang, Sekhar Surapaneni

By Donglu Zhang, Sekhar Surapaneni

A finished consultant to state-of-the-art instruments in ADME research

The final decade has obvious large growth within the improvement of analytical strategies akin to mass spectrometry and molecular biology instruments, leading to vital advances in drug discovery, fairly within the zone of absorption, distribution, metabolism, and excretion (ADME).

ADME-Enabling applied sciences in Drug layout and improvement specializes in the present state-of-the-art within the box, offering a finished evaluate of the most recent instruments for producing ADME facts in drug discovery. It examines the broadest attainable variety of obtainable applied sciences, giving readers the data they should opt for the best instrument for a given software, a key considered necessary for acquiring favorable leads to a well timed model for regulatory filings. With over thirty contributed chapters by way of a global group of specialists, the publication provides:

  • A thorough exam of present instruments, masking either electronic/mechanical applied sciences and biologically dependent ones

  • Coverage of functions for every know-how, together with key parameters, optimum stipulations for meant effects, protocols, and case studies

  • Detailed dialogue of rising instruments and methods, from stem cells and genetically transformed animal types to imaging technologies

  • Numerous figures and diagrams through the text

Scientists and researchers in drug metabolism, pharmacology, medicinal chemistry, pharmaceutics, toxicology, and bioanalytical technological know-how will locate ADME-Enabling applied sciences in Drug layout and improvement a useful advisor to the whole drug improvement procedure, from discovery to regulatory matters

Show description

Read Online or Download ADME-Enabling Technologies in Drug Design and Development PDF

Best pharmacy books

Enantiomer Separation: Fundamentals and Practical Methods

Many vital pharmaceutical medicines, chemical compounds for the natural synthesis of chiral compounds, digital parts similar to liquid crystals, and polymeric fabrics are chiral (enantiomeric). the advance of latest useful equipment for the training of enantiomerically natural ingredients is therefore important.

Neuropeptide Y and Drug Development

Neuropeptide Y (NPY) is a ubiquitous and demanding messenger within the anxious method, with a variety of physiological roles. it truly is focused on the physique power stability and is likely one of the so much powerful stimuli of nutrition consumption recognized. NPY additionally acts to control relevant and peripheral autonomic capabilities. This booklet, written via educational and commercial specialists within the box, hyperlinks the latest simple experimental wisdom approximately NPY and its receptors with parts of scientific value.

Modified Nucleosides: in Biochemistry, Biotechnology and Medicine

Edited through one of many major using forces at the back of the field's momentous upward thrust lately, this one-stop reference is the 1st complete source to combine contemporary advances. the 1st half addresses biochemical elements and functions, the second one and 3rd components are dedicated to compounds with healing capability, with the 3rd half targeting newly brought anticancer nucleoside medicines.

Dose Optimization in Drug Development

Arguably the main tricky element of drug improvement, as soon as proof-of-concept is accomplished for a singular mechanism, is defining the “right” dose. certainly, the query swiftly expands to correct for whom? a person? A inhabitants? a particular ailment? a distinct demographic? The solutions can yield a dizzying array of possible choices.

Additional info for ADME-Enabling Technologies in Drug Design and Development

Example text

The title 21 of the federal register (21 CFR 312) contains the regulations regard- Testing Scheme Target identification and validation, in vitro efficacy assays, physical-chemistry assays In vivo efficacy assays (preclinical proof of concept), in vitro ADME assays, and preliminary PK and toxicology studies PK/PD modeling, salt form selection, crystal form assessment; good laboratory practice (GLP) toxicology studies: genetic toxicology, safety pharmacology, in vivo toxicology in two species First–in-human dose, safety and tolerability in normal healthy volunteers Safety and tolerability in patients, early clinical proof of principle Definitive clinical proof of principle Postmarketing safety review ing the IND applications.

The FDA also recommended that when the information has important implications for the safe and effective use of the drug and the drug metabolism information results in recommendations for dosage adjustments, contraindications, or warnings, this information should be included in the appropriate sections, such as boxed warning, dosage and administration, contraindications, and drug interactions. The drug metabolism information is captured in the “Clinical Pharmacology” section of the prescription label under the subsections of Pharmacokinetics, Absorption, Distribution, Metabolism, and Excretion.

2 NONCLINICAL OVERVIEW Nonclinical overview presents the summary of information related to pharmacology, PK/ADME, and toxicology. Nonclinical PK information in this section is not intended to contain a summary of each study conducted. The purposes are to integrate drug metabolism information generated across studies and to provide a summary of findings that may have safety and efficacy implications. Taking the pharmacology, PK, and toxicology results into account, the implications of the nonclinical findings for safe human use of the pharmaceutical should be discussed.

Download PDF sample

Rated 4.97 of 5 – based on 20 votes